Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1 + 566 word(s) 566 2020-12-15 07:41:43 |
2 format correct -3 word(s) 563 2020-12-24 09:02:04 |

Video Upload Options

Do you have a full video?


Are you sure to Delete?
If you have any further questions, please contact Encyclopedia Editorial Office.
Ren, B. X-linked Chondrodysplasia Punctata 1. Encyclopedia. Available online: (accessed on 23 June 2024).
Ren B. X-linked Chondrodysplasia Punctata 1. Encyclopedia. Available at: Accessed June 23, 2024.
Ren, Bruce. "X-linked Chondrodysplasia Punctata 1" Encyclopedia, (accessed June 23, 2024).
Ren, B. (2020, December 24). X-linked Chondrodysplasia Punctata 1. In Encyclopedia.
Ren, Bruce. "X-linked Chondrodysplasia Punctata 1." Encyclopedia. Web. 24 December, 2020.
X-linked Chondrodysplasia Punctata 1

X-linked chondrodysplasia punctata 1 is a disorder of cartilage and bone development that occurs almost exclusively in males. Chondrodysplasia punctata is an abnormality that appears on x-rays as spots (stippling) near the ends of bones and in cartilage.

genetic conditions

1. Introduction

In most infants with X-linked chondrodysplasia punctata 1, this stippling is seen in bones of the ankles, toes, and fingers; however, it can also appear in other bones. The stippling generally disappears in early childhood.

Other characteristic features of X-linked chondrodysplasia punctata 1 include short stature and unusually short fingertips and ends of the toes. This condition is also associated with distinctive facial features, particularly a flattened-appearing nose with crescent-shaped nostrils and a flat nasal bridge.

People with X-linked chondrodysplasia punctata 1 typically have normal intelligence and a normal life expectancy. However, some affected individuals have had serious or life-threatening complications including abnormal thickening (stenosis) of the cartilage that makes up the airways, which restricts breathing. Also, abnormalities of spinal bones in the neck can lead to pinching (compression) of the spinal cord, which can cause pain, numbness, and weakness. Other, less common features of X-linked chondrodysplasia punctata 1 include delayed development, hearing loss, vision abnormalities, and heart defects.

2. Frequency

The prevalence of X-linked chondrodysplasia punctata 1 is unknown. Several dozen affected males have been reported in the scientific literature.

3. Causes

X-linked chondrodysplasia punctata 1 is caused by genetic changes involving the ARSL gene. This gene provides instructions for making an enzyme called arylsulfatase E. The function of this enzyme is unknown, although it appears to be important for normal skeletal development and is thought to participate in a chemical pathway involving vitamin K. Evidence suggests that vitamin K normally plays a role in bone growth and maintenance of bone density.

Between 60 and 75 percent of males with the characteristic features of X-linked chondrodysplasia punctata 1 have a mutation in the ARSL gene. These mutations reduce or eliminate the function of arylsulfatase E. Another 25 percent of affected males have a small deletion of genetic material from the region of the X chromosome that contains the ARSL gene. These individuals are missing the entire gene, so their cells produce no functional arylsulfatase E. Researchers are working to determine how a shortage of arylsulfatase E disrupts the development of bones and cartilage and leads to the characteristic features of X-linked chondrodysplasia punctata 1.

Some people with the features of X-linked chondrodysplasia punctata 1 do not have an identified mutation in the ARSE gene or a deletion involving the gene. Other, as-yet-unidentified genetic and environmental factors may also be involved in causing this disorder.

4. Inheritance

This condition is inherited in an X-linked recessive pattern. The gene associated with this condition is located on the X chromosome, which is one of the two sex chromosomes. In males (who have only one X chromosome), one altered copy of the ARSL gene in each cell is sufficient to cause the condition. In females (who have two X chromosomes), a mutation would have to occur in both copies of the gene to cause the disorder. Because it is unlikely that females will have two altered copies of this gene, males are affected by X-linked recessive disorders much more frequently than females. A characteristic of X-linked inheritance is that fathers cannot pass X-linked traits to their sons.

5. Other Names for This Condition

  • arylsulfatase E deficiency
  • CDPX1
  • chondrodysplasia punctata 1, X-linked
  • X-linked recessive chondrodysplasia punctata 1


  1. Braverman NE, Bober MB, Brunetti-Pierri N, Suchy SF. Chondrodysplasia Punctata1, X-Linked. 2008 Apr 22 [updated 2020 Oct 15]. In: Adam MP, Ardinger HH, PagonRA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews®[Internet]. Seattle (WA): University of Washington, Seattle; 1993-2020. Availablefrom
  2. Brunetti-Pierri N, Andreucci MV, Tuzzi R, Vega GR, Gray G, McKeown C, BallabioA, Andria G, Meroni G, Parenti G. X-linked recessive chondrodysplasia punctata:spectrum of arylsulfatase E gene mutations and expanded clinical variability. Am J Med Genet A. 2003 Mar 1;117A(2):164-8.
  3. Casarin A, Rusalen F, Doimo M, Trevisson E, Carraro S, Clementi M, Tenconi R, Baraldi E, Salviati L. X-linked brachytelephalangic chondrodysplasia punctata: a simple trait that is not so simple. Am J Med Genet A. 2009 Nov;149A(11):2464-8.doi: 10.1002/ajmg.a.33039.
  4. Daniele A, Parenti G, d'Addio M, Andria G, Ballabio A, Meroni G. Biochemicalcharacterization of arylsulfatase E and functional analysis of mutations found inpatients with X-linked chondrodysplasia punctata. Am J Hum Genet. 1998Mar;62(3):562-72.
  5. Garnier A, Dauger S, Eurin D, Parisi I, Parenti G, Garel C, Delbecque K,Baumann C. Brachytelephalangic chondrodysplasia punctata with severe spinal cord compression: report of four new cases. Eur J Pediatr. 2007 Apr;166(4):327-31.
  6. Maroteaux P. Brachytelephalangic chondrodysplasia punctata: a possibleX-linked recessive form. Hum Genet. 1989 May;82(2):167-70.
  7. Nino M, Matos-Miranda C, Maeda M, Chen L, Allanson J, Armour C, Greene C,Kamaluddeen M, Rita D, Medne L, Zackai E, Mansour S, Superti-Furga A, Lewanda A, Bober M, Rosenbaum K, Braverman N. Clinical and molecular analysis ofarylsulfatase E in patients with brachytelephalangic chondrodysplasia punctata.Am J Med Genet A. 2008 Apr 15;146A(8):997-1008. doi: 10.1002/ajmg.a.32159.
  8. Sheffield LJ, Osborn AH, Hutchison WM, Sillence DO, Forrest SM, White SJ, DahlHH. Segregation of mutations in arylsulphatase E and correlation with theclinical presentation of chondrodysplasia punctata. J Med Genet. 1998Dec;35(12):1004-8.
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to :
View Times: 615
Entry Collection: MedlinePlus
Revisions: 2 times (View History)
Update Date: 24 Dec 2020
Video Production Service